Fact CheckerSign in

NCT06356077Completed

SHINE: Trends and Satisfaction in Hypertensives Using Aktiia Optical BP Monitoring Device (SHINE)

SHINE Study: Blood Pressure Evolution and User Satisfaction in a Hypertensive Population Using the Aktiia 24/7 Optical Blood Pressure Monitoring (OBPM) Device: a Prospective Observational Cohort Study.

Source: ClinicalTrials.gov · Last updated 18 Sept 2025

Brief summary (registry, in English)

The SHINE study aims to gather data on the evolution of participant's blood pressure and to correlate this with demographic, lifestyle and health factors in a hypertensive population as well as, to gather data on participants' perception of the device under test (Aktiia 24/7).

Status (registry)
Completed
Study type
Observational
Enrollment
1729 (actual)
First submitted
20 Mar 2024
Start date
31 Jul 2024
Primary completion date
30 Apr 2025
Lead sponsor
Aktiia SA
NCT number
NCT06356077

What you commit to

  • Study type: Observational
  • Participants enrolled: 1729
  • From 31 Jul 2024 to the primary completion date, 30 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participation in another interventional clinical study or use of investigational drugs in the last 30 days.

Other illness

  • Participants with a self-reported known diagnosis of
    • atrial fibrillation
    • congestive heart failure
    • heart valve disease
    • pheochromocytoma
    • Raynaud's disease
    • arm lymphedema

Other

  • Participants whose BP data submitted is \>180 mm Hg systolic OR \>120 mm Hg diastolic .
  • Participants who take insulin
  • Participants who are on hemodialysis
  • Women who are self-reported to be pregnant
  • Participants whose arms shake uncontrollably or are paralyzed (cannot move)
  • Participants with upper arm circumference \<22 cm or \>42 cm
  • Participants with wrist circumference \>23cm

Who the study is looking for

  • Adult participants aged 22 to 85 years old
  • A participant whose last blood pressure reading was within the last 12 months and was either:
    • SBP ≥145
    • or ≥DBP 90
  • People who use either an iOS or Android smartphone
  • People who have 2 arms
  • Able and willing to provide informed consent and to adhere to study procedures.

Age in the registry: 21 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Lindus Health
Coordinator of this site? Confirm its status
LondonUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.